Clinical Trial Update: Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating AMG 301 for prevention of chronic or episodic migraine has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• AMG 301

Snippet

Sponsor: Amgen | Conditions: Chronic Migraine or Episodic Migraine | Phase 2 | Status: COMPLETED | Results posted: 2020-02-07